Regeneron Pharmaceuticals reported $3.42B in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -62.63M 0.05M
Agenus AGEN:US $ -64.67M 25.03M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -134.35M 39.3M
Amgen AMGN:US $ 3188M 218M
Astellas Pharma 4503:JP Y 53942M 59543M
AstraZeneca AZN:LN 2149M 322M
Biogen BIIB:US $ 1147.6M 41.7M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Bristol Myers Squibb BMY:US $ 5679M 455M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Esperion Therapeutics ESPR:US $ -32380000 50.29M
Gilead Sciences GILD:US $ 2816M 669M
GlaxoSmithKline GSK:LN 2626M 584M
Intercept Pharmaceuticals ICPT:US $ 1.39M 29.71M
IONIS PHARMACEUT IONS:US $ -68.34M 19.17M
Johnson & Johnson JNJ:US $ 8103M 786M
Kyowa Hakko Kirin 4151:JP Y 19755M 131M
Moderna Inc MRNA:US 3.13B 1.85B
Neurocrine Biosciences NBIX:US $ 70.4M 36.4M
Novartis NOVN:VX SF 4772M 423M
Novartis NVS:US $ 4772M 423M
Pfizer PFE:US $ 7593M 610M
Puma Biotechnology PBYI:US $ -13.7M 36.8M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Sarepta Therapeutics SRPT:US $ -159.13M 26.19M
Seattle Genetics SGEN:US $ -73.78M 33.35M
Teva Pharmaceutical TEVA:IT 1.14B 34M
Ultragenyx Pharmaceutical RARE:US $ -79.66M 23.55M
United Therapeutics UTHR:US $ 234.6M 263.8M
Vertex Pharmaceuticals VRTX:US $ -5.12M 917.88M
YTE INCY:US $ 169.77M 41.12M